Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43. doi: 10.1158/1055-9965.EPI-11-0419. Epub 2011 Jul 12.

2.

Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer.

Fogh S, Hirsch AE, Langmead JP, Goldberg SI, Rosenberg CL, Taghian AG, Powell SN, Kachnic LA.

Clin Breast Cancer. 2011 Mar;11(1):39-45. doi: 10.3816/CBC.2011.n.007.

PMID:
21421521
3.

Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.

Hannafon BN, Sebastiani P, de las Morenas A, Lu J, Rosenberg CL.

Breast Cancer Res. 2011 Mar 4;13(2):R24. doi: 10.1186/bcr2839.

4.

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Garne JP, Sørensen HT, Hellberg Y, Christensen M, Pedersen L, Hamilton-Dutoit S.

J Natl Cancer Inst. 2011 Mar 16;103(6):489-500. doi: 10.1093/jnci/djr010. Epub 2011 Feb 15.

5.

Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Rosenberg CL, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Clin Epidemiol. 2010 Oct 22;2:241-6. doi: 10.2147/CLEP.S13811.

6.

Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.

Graham K, Ge X, de Las Morenas A, Tripathi A, Rosenberg CL.

Clin Cancer Res. 2011 Jan 15;17(2):236-46. doi: 10.1158/1078-0432.CCR-10-1369. Epub 2010 Nov 8.

7.

Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.

Graham K, de las Morenas A, Tripathi A, King C, Kavanah M, Mendez J, Stone M, Slama J, Miller M, Antoine G, Willers H, Sebastiani P, Rosenberg CL.

Br J Cancer. 2010 Apr 13;102(8):1284-93. doi: 10.1038/sj.bjc.6605576. Epub 2010 Mar 2.

8.

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT, Pedersen L.

Acta Oncol. 2010 Apr;49(3):305-12. doi: 10.3109/02841860903575273.

9.

Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy.

Lash TL, Rosenberg CL.

J Clin Oncol. 2010 Mar 10;28(8):1273-5. doi: 10.1200/JCO.2009.26.7906. Epub 2010 Feb 1. No abstract available.

PMID:
20124162
10.

Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression.

Emery LA, Tripathi A, King C, Kavanah M, Mendez J, Stone MD, de las Morenas A, Sebastiani P, Rosenberg CL.

Am J Pathol. 2009 Sep;175(3):1292-302. doi: 10.2353/ajpath.2009.090115. Epub 2009 Aug 21.

11.

Triple-negative breast cancers are increased in black women regardless of age or body mass index.

Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL.

Breast Cancer Res. 2009;11(2):R18. doi: 10.1186/bcr2242. Epub 2009 Mar 25.

12.

Polysomy 17 and HER-2 amplification: true, true, and unrelated.

Rosenberg CL.

J Clin Oncol. 2008 Oct 20;26(30):4856-8. doi: 10.1200/JCO.2008.17.2684. Epub 2008 Sep 15. No abstract available.

PMID:
18794542
13.

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT.

Br J Cancer. 2008 Aug 19;99(4):616-21. doi: 10.1038/sj.bjc.6604533. Epub 2008 Jul 29.

14.

Modification of tamoxifen response: what have we learned?

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Kvistgaard ME, Rosenberg CL, Silliman RA, Sørensen HT.

J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432. No abstract available.

PMID:
18375910
15.

CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer.

Larson PS, Schlechter BL, King CL, Yang Q, Glass CN, Mack C, Pistey R, de Las Morenas A, Rosenberg CL.

BMC Cancer. 2008 Mar 6;8:68. doi: 10.1186/1471-2407-8-68.

16.

Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.

Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Lenburg ME, Rosenberg CL.

Int J Cancer. 2008 Apr 1;122(7):1557-66.

17.

A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.

Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, Splansky GL, Antman K, Hwang SJ.

BMC Med Genet. 2007 Sep 19;8 Suppl 1:S6.

18.

Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.

Sane R, Baribeault D, Rosenberg CL.

Pharmacotherapy. 2007 Apr;27(4):613-5.

PMID:
17381390
19.

In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.

Larson PS, Ungarelli RA, de Las Morenas A, Cupples LA, Rowlings K, Palmer JR, Rosenberg CL.

Cancer. 2006 Nov 1;107(9):2122-6.

20.

Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.

Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL.

J Pathol. 2006 Jul;209(3):307-16.

PMID:
16604511
21.
22.
23.

Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence.

Schlechter BL, Yang Q, Larson PS, Golubeva A, Blanchard RA, de las Morenas A, Rosenberg CL.

J Clin Oncol. 2004 May 15;22(10):1830-8.

PMID:
15143075
24.

Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer.

Wang Q, Larson PS, Schlechter BL, Zahid N, Finnemore E, de las Morenas A, Blanchard RA, Rosenberg CL.

Int J Cancer. 2003 Oct 10;106(6):923-9.

25.

Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).

Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN.

Cancer Causes Control. 2002 Oct;13(8):753-8.

PMID:
12420954
26.
27.

Are oral appliances a substitute for nasal positive airway pressure?

Millman RP, Rosenberg CL.

Thorax. 2002 Apr;57(4):283-4. No abstract available.

28.

DNA alterations in tumor scrapes vs. biopsies of squamous-cell carcinomas of the head and neck.

Rosenberg CL, Finnemore EM, Larson PS, Nogueira CP, Delaney TL.

Int J Cancer. 2000 Mar 20;89(2):105-10.

29.

Lack of correlation between morphometric analysis and presence of microsatellite alterations in proliferative ductal lesions of the breast.

Zucca MP, Larson PS, Rosenberg CL, de las Morenas A.

Anal Quant Cytol Histol. 1999 Oct;21(5):369-73.

PMID:
10560518
30.

Oral appliances in the treatment of snoring and sleep apnea

Millman RP, Rosenberg CL, Kramer NR.

Otolaryngol Clin North Am. 1998 Dec;31(6):1039.

PMID:
9838016
31.

Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.

Lazar AD, Winter MR, Nogueira CP, Larson PS, Finnemore EM, Dolan RW, Fuleihan N, Chakravarti A, Zietman A, Rosenberg CL.

Clin Cancer Res. 1998 Nov;4(11):2787-93.

32.

Genetically abnormal clones in histologically normal breast tissue.

Larson PS, de las Morenas A, Cupples LA, Huang K, Rosenberg CL.

Am J Pathol. 1998 Jun;152(6):1591-8.

33.

The efficacy of oral appliances in the treatment of persistent sleep apnea after uvulopalatopharyngoplasty.

Millman RP, Rosenberg CL, Carlisle CC, Kramer NR, Kahn DM, Bonitati AE.

Chest. 1998 Apr;113(4):992-6.

PMID:
9554637
34.

Oral appliances in the treatment of snoring and sleep apnea.

Millman RP, Rosenberg CL, Kramer NR.

Clin Chest Med. 1998 Mar;19(1):69-75. Review.

PMID:
9554218
35.

Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer.

Rosenberg CL, Larson PS, Romo JD, De Las Morenas A, Faller DV.

Hum Pathol. 1997 Feb;28(2):214-9.

PMID:
9023405
36.

Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

Rosenberg CL, de las Morenas A, Huang K, Cupples LA, Faller DV, Larson PS.

J Clin Invest. 1996 Sep 1;98(5):1095-100.

37.

A dental and medical approach to sleep apnea. Part II: Treatment options for obstructive sleep apnea.

Rosenberg CL, Millman RP.

R I Dent J. 1996 Spring;29(1):5, 7-8. Review. No abstract available.

PMID:
9495921
38.

Chromosomal translocations in secondary acute myeloid leukemia.

Rowley JD, Vignon C, Gollin SM, Rosenberg CL, Wyandt HE, Milunsky A.

N Engl J Med. 1996 Feb 29;334(9):601-3. No abstract available.

PMID:
8569841
39.

Efficacy of a Herbst mandibular advancement device in obstructive sleep apnea.

Eveloff SE, Rosenberg CL, Carlisle CC, Millman RP.

Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):905-9.

PMID:
8143054
40.

Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.

Rosenberg CL, Motokura T, Kronenberg HM, Arnold A.

Oncogene. 1993 Feb;8(2):519-21.

PMID:
8426754
41.

Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.

Williams ME, Swerdlow SH, Rosenberg CL, Arnold A.

Leukemia. 1993 Feb;7(2):241-5.

PMID:
8426477
42.

Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.

Williams ME, Swerdlow SH, Rosenberg CL, Arnold A.

Cancer Res. 1992 Oct 1;52(19 Suppl):5541s-5544s.

43.

Centrocytic lymphoma: a B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements.

Williams ME, Swerdlow SH, Rosenberg CL, Arnold A.

Curr Top Microbiol Immunol. 1992;182:325-9. No abstract available.

PMID:
1490371
44.

PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.

Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A.

Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9638-42.

45.

Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.

Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A.

Oncogene. 1991 Mar;6(3):449-53.

PMID:
2011400
46.

Beware the legal booby traps of hospital committees.

Rosenberg CL.

Med Econ. 1985 Jul 22;62(15):110-4. No abstract available.

PMID:
10271945
47.

The elderly. How you'll feel their political muscle.

Rosenberg CL.

Med Econ. 1985 Apr 29;62(9):51-3, 56-9. No abstract available.

PMID:
10271156
48.

How bad doctors dodge discipline.

Rosenberg CL.

Med Econ. 1985 Mar 18;62(6):241-5, 249-56. No abstract available.

PMID:
10270380
49.

Doctor-owned malpractice carriers: who's winning, who's losing.

Rosenberg CL.

Med Econ. 1984 Oct 1;61(20):62-71. No abstract available.

PMID:
10268383
50.

When peers put the heat on doctors who overhospitalize.

Rosenberg CL.

Med Econ. 1984 Sep 3;61(18):106, 110, 115-8. No abstract available.

PMID:
10268001

Supplemental Content

Loading ...
Support Center